Literature DB >> 29045202

Amyotrophic Lateral Sclerosis.

Robert H Brown1, Ammar Al-Chalabi2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 29045202     DOI： 10.1056/NEJMc1710379

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  45 in total

1.  Arginine-rich dipeptide-repeat proteins as phase disruptors in C9-ALS/FTD.

Authors:  Hana M Odeh; James Shorter
Journal:  Emerg Top Life Sci       Date:  2020-12-11

2.  Androgen receptor antagonism accelerates disease onset in the SOD1G93A mouse model of amyotrophic lateral sclerosis.

Authors:  Victoria M McLeod; Chew L Lau; Mathew D F Chiam; Thusitha W Rupasinghe; Ute Roessner; Elvan Djouma; Wah C Boon; Bradley J Turner
Journal:  Br J Pharmacol       Date:  2019-05-23       Impact factor: 8.739

3.  Single-cell transcriptomics identifies master regulators of neurodegeneration in SOD1 ALS iPSC-derived motor neurons.

Authors:  Seema C Namboori; Patricia Thomas; Ryan Ames; Sophie Hawkins; Lawrence O Garrett; Craig R G Willis; Alessandro Rosa; Lawrence W Stanton; Akshay Bhinge
Journal:  Stem Cell Reports       Date:  2021-11-11       Impact factor: 7.765

Review 4.  The emerging role of complement in neuromuscular disorders.

Authors:  John D Lee; Trent M Woodruff
Journal:  Semin Immunopathol       Date:  2021-10-27       Impact factor: 9.623

Review 5.  Phase separation of low-complexity domains in cellular function and disease.

Authors:  Jiwon Lee; Hana Cho; Ilmin Kwon
Journal:  Exp Mol Med       Date:  2022-09-29       Impact factor: 12.153

6.  Embedded Palliative Care for Amyotrophic Lateral Sclerosis: A Pilot Program and Lessons Learned.

Authors:  Kelly Fahrner-Scott; Carly Zapata; David L O'Riordan; Eve Cohen; Laura Rosow; Steven Z Pantilat; Catherine Lomen-Hoerth; Kara E Bischoff
Journal:  Neurol Clin Pract       Date:  2022-02

Review 7.  Lysosome dysfunction as a cause of neurodegenerative diseases: Lessons from frontotemporal dementia and amyotrophic lateral sclerosis.

Authors:  Jessica Root; Paola Merino; Austin Nuckols; Michelle Johnson; Thomas Kukar
Journal:  Neurobiol Dis       Date:  2021-03-31       Impact factor: 7.046

8.  Residential exposure to electromagnetic fields and risk of amyotrophic lateral sclerosis: a dose-response meta-analysis.

Authors:  Tommaso Filippini; Elizabeth E Hatch; Marco Vinceti
Journal:  Sci Rep       Date:  2021-06-07       Impact factor: 4.379

9.  Transcriptome analysis using patient iPSC-derived skeletal myocytes: Bet1L as a new molecule possibly linked to neuromuscular junction degeneration in ALS.

Authors:  Eileen M Lynch; Samantha Robertson; Claire FitzGibbons; Megan Reilly; Colton Switalski; Adam Eckardt; Sin-Ruow Tey; Koji Hayakawa; Masatoshi Suzuki
Journal:  Exp Neurol       Date:  2021-07-24       Impact factor: 5.330

10.  Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral Sclerosis.

Authors:  Sabrina Paganoni; Eric A Macklin; Suzanne Hendrix; James D Berry; Michael A Elliott; Samuel Maiser; Chafic Karam; James B Caress; Margaret A Owegi; Adam Quick; James Wymer; Stephen A Goutman; Daragh Heitzman; Terry Heiman-Patterson; Carlayne E Jackson; Colin Quinn; Jeffrey D Rothstein; Edward J Kasarskis; Jonathan Katz; Liberty Jenkins; Shafeeq Ladha; Timothy M Miller; Stephen N Scelsa; Tuan H Vu; Christina N Fournier; Jonathan D Glass; Kristin M Johnson; Andrea Swenson; Namita A Goyal; Gary L Pattee; Patricia L Andres; Suma Babu; Marianne Chase; Derek Dagostino; Samuel P Dickson; Noel Ellison; Meghan Hall; Kent Hendrix; Gale Kittle; Michelle McGovern; Joseph Ostrow; Lindsay Pothier; Rebecca Randall; Jeremy M Shefner; Alexander V Sherman; Eric Tustison; Prasha Vigneswaran; Jason Walker; Hong Yu; James Chan; Janet Wittes; Joshua Cohen; Justin Klee; Kent Leslie; Rudolph E Tanzi; Walter Gilbert; Patrick D Yeramian; David Schoenfeld; Merit E Cudkowicz
Journal:  N Engl J Med       Date:  2020-09-03       Impact factor: 176.079
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.